Page 61 - Sohini Das

Temporary Covid-19 centres getting dismantled amid signs pandemic is ending

About 92% of cases in India are said to be having mild disease. In only 5.8% of cases oxygen therapy is required, intensive care in only 1.7% cases

India's first Covid cure Vincov-19 completes second phase clinical trial

These highly purified antibody fragments have a high neutralising capacityagainst the Sars-CoV-2 virus

Indian Immunologicals to double foot and mouth disease vaccine capacity

To Invest Rs 700 crore in Hyderabad for new animal vaccine facility

Maiden Pharma may lose import-export code over cough syrup deaths in Gambia

Pharmexcil suspends membership; may recommend DGFT to withdraw Import-Export Code

Advisory board urges ban on codeine cough drugs, regulator to take call

Codeine formulations constitute 8% of cough and cold market; pharma industry asks govt not to ban a 'safe' medicine for abuse by some

Maiden Pharma's cough syrups, under WHO scanner, not sold in India: Sources

Meanwhile, the Indian regulator is awaiting evidence of links between the cough syrups and the deaths in Gambia

Haryana drug firm under WHO scanner for supplying contaminated drugs

Maiden Pharma has manufactured and exported the products only to Gambia so far

Over 100 million Covid-19 vaccine doses wasted in India by September-end

Covid-19 vaccine makers have no plans to seek further shelf life extensions

Registration by medical device resellers made a must, may impact mask sales

Apart from masks, even condoms sold at groceries may be brought within the ambit of the rule; industry feels govt may come out with an exemption list for common items

End of the pandemic in sight, but is it time to let down the guard?

While the world is moving away from the most basic Covid-19 protocols, some experts say it is too early to declare that the pandemic is over

Existing pharma marketing practices code is adequate: Centre tells SC

Says Indian Pharmaceutical Alliance's investigation report cleared Dolo-650 maker, Micro Labs, of allegations of bribing doctors with freebies worth Rs 1,000 crore

India's Alzheimer's burden is growing, but treatment still out of reach

Doctors say there is no national-level policy programme for Alzheimer's and the bulk of the family expenditure on health is on people in their productive ages

How artificial intelligence is making diagnosis faster and more accurate

It addresses the shortage of radiologists and pathologists and frees up doctors to deal with complex cases

Amrit Mahotsav campaign pushed Covid booster dose coverage to 27%

The 75-day-long Amrit Mahotsav campaign also helped salvage wastage of vaccine doses

Pharma industry says taking steps to check misuse of codeine drugs

Sales declining anyway and there is no need to ban because of alleged misuse, say experts

Rakuten Medical trying to commercialise novel cancer therapy in India

India accounts for around 26 percent of all head and neck cancer cases globally

Krsnaa Diagnostics enters B2C segment with chain of 600 diagnostic centres

Mainly a PPP and B2B player, the Pune-based chain offers disruptive pricing

Bayer launches novel heart failure drug Verquvo for Rs 127 a pill

In India there are between 8-10 million people with heart failure, making it one of the world's largest populations with the malady

Torrent Pharma acquires cosmetic derma player Curatio for Rs 2,000 cr

First major acquisition by Aman Mehta after taking charge at Torrent Pharma in August

Stay committed to patients in India and Fortis Healthcare, says IHH

Taking legal advice on next steps to pursue open offer for 26% stake in Fortis